Clinical manifestations are complex and often involve multiple systemic burdens. Early identification and standardized clinical care are critical to improving prognosis. Diagnosis of the disease requires a combination of clinical manifestations, imaging inspections, laboratory tests, and pathological evaluation.
The platform can assist in matching teams of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. Treatment programs for the treatment and management of MSD require individual development, usually including pharmacotherapy, rehabilitation interventions, regular follow-up, and other multidimensional management. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many of the neural system disorders that have previously been difficult to treat have been significantly improved.
Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to timely scheduling according to the changes in the condition. Multidisciplinary collaboration (MDT) is particularly important for the integrated management of spinal cord mesothelioma type 2. 2.
Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3. Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.